Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?: a review article

BACKGROUND: Optimal antithrombotic therapy depicts a challenge to clinicians treating atrial fibrillation (AF) patients who are undergoing percutaneous coronary intervention (PCI). Theoretically, these patients would require a combination therapy of oral anticoagulant and dual antiplatelet therapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshahrani, Ali, O’Nunain, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462590/
https://www.ncbi.nlm.nih.gov/pubmed/37639078
http://dx.doi.org/10.1186/s43044-023-00402-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462590/
https://www.ncbi.nlm.nih.gov/pubmed/37639078
http://dx.doi.org/10.1186/s43044-023-00402-0

Ejemplares similares